BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Enzon Incorporated

Below is an extended Enzon Incorporated research listing. Click here to return to the Enzon Incorporated main Biocorporate entry.

Recent Publications by Enzon Incorporated:

Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers.
CPT-11, also known as irinotecan, is a prodrug that is approved for the...
29th July, 2008
Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, New Jersey Bioconjug Chem. 2008 Apr;19(4):849-59. Epub 2008 Mar 28.
DOI Direct Link
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
PURPOSE: Clinical development of SN38, the active metabolite of...
21st May, 2008
Enzon Pharmaceuticals, Inc., Piscataway, New Jersey 08854, USA. Clin Cancer Res. 2008 Mar 15;14(6):1888-96.
DOI Direct Link
Releasable PEGylation of proteins with customized linkers.
Releasable PEGylation employs customized linkers that reversibly tether a...
6th May, 2008
Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, New Jersey Adv Drug Deliv Rev. 2008 Jan 3;60(1):29-49. Epub 2007 Aug 16.
DOI Direct Link
Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice.
Recombinant immunotoxins exhibit targeting and cytotoxic functions needed...
30th August, 2007
Enzon Pharmaceuticals, Incorporated, 20 Kingsbridge Road, Piscataway, New Bioconjug Chem. 2007 May-Jun;18(3):773-84. Epub 2007 Mar 9.
DOI Direct Link
Antibody engineering and modification technologies.
Antibody engineering has become a well-developed discipline, encompassing...
27th July, 2007
Enzon Pharmaceuticals, Piscataway, NJ 08854-3969, USA. Biomol Eng. 2007 Jun;24(2):201-15. Epub 2007 Mar 31.
DOI Direct Link
Delivery of G3139 using releasable PEG-linkers: impact on pharmacokinetic profile and anti-tumor efficacy.
In order to overcome the problems of enzymatic degradation and short...
11th July, 2007
Enzon Pharmaceuticals, 20 Kingsbridge Road, Piscataway, NJ 08820, United J Control Release. 2007 Jun 4;119(2):143-52. Epub 2006 Dec 29.
DOI Direct Link
Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC).
ABELCET, an amphotericin B lipid complex formulation (ABLC) and an...
8th February, 2007
Enzon Pharmaceuticals, Inc., Piscataway, New Jersey 08854, USA. Int J Toxicol. 2006 Nov-Dec;25(6):487-92.
DOI Direct Link
Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Antitumor effect of poly(ethylene glycol)-camptothecin conjugate (PEG-CPT)...
20th January, 2007
Enzon Pharmaceuticals, Inc., Piscataway, NJ 08854, USA. J Control Release. 2005 Dec 10;110(1):90-102. Epub 2005 Nov 4.
DOI Direct Link
Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
Arginine is an important metabolite in the normal function of several...
16th January, 2007
Enzon Pharmaceuticals, 20 Kingsbridge Road, Piscataway, New Jersey Bioconjug Chem. 2006 Nov-Dec;17(6):1447-59.
DOI Direct Link
Safety evaluation of ABELCET, an amphotericin B lipid complex (ABLC): toxicity studies in rats.
ABELCET (ABLC) is a widely used amphotericin B lipid complex formulation...
19th August, 2006
Enzon Pharmaceuticals, Inc., Piscataway, New Jersey, USA. Int J Toxicol. 2006 Jul-Aug;25(4):285-94.
DOI Direct Link
Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
Recombinant interferon-beta-1b (IFN-beta-1b) is used clinically in the...
25th July, 2006
Enzon Pharmaceuticals, 20 Kingsbridge Road, Piscataway, New Jersey Bioconjug Chem. 2006 May-Jun;17(3):618-30.
DOI Direct Link
Linear and branched bicin linkers for releasable PEGylation of macromolecules: controlled release in vivo and in vitro from mono- and multi-PEGylated proteins.
The utility of PEGylation for improving therapeutic protein pharmacology...
13th July, 2006
Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, New Jersey Bioconjug Chem. 2006 Mar-Apr;17(2):341-51.
DOI Direct Link
An unexpected amide bond cleavage: poly (ethylene glycol) transport forms of vancomycin. 2.
PEG-amide vancomycin derivatives (V(3) position) have been synthesized and...
7th January, 2006
Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, NJ 08854, Eur J Med Chem. 2005 Aug;40(8):798-804. Epub 2005 Apr 22.
DOI Direct Link
A new platform for oligonucleotide delivery utilizing the PEG prodrug approach.
The oligonucleotide (oligo, ODN), Genasense (GS), an ODN currently waiting...
13th December, 2005
Enzon Pharmaceuticals Inc., 20 Kingsbridge Road, Piscataway, New Jersey Bioconjug Chem. 2005 Jul-Aug;16(4):758-66.
DOI Direct Link

«Enzon Incorporated

This page contained an extended Enzon Incorporated research listing. Click here to return to the Enzon Incorporated main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.